secwatch.observer — SEC 8-K summary
======================================

Issuer:     Perspective Therapeutics, Inc. (CATX)
CIK:        0000728387
Form:       8-K
Filed at:   2025-09-04T23:59:59+00:00
Accession:  0000728387-25-000013
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Perspective Therapeutics appoints Joel Sendek as CFO, replacing Juan Graham
---------------------------------------------------------------------------

- Effective Sept 4, 2025; Sendek brings over 30 years of biotech finance and equity research experience.
- Sendek previously served as CFO at four biotech firms and raised over $2.5B in capital.
- Compensation: $500k base salary, 40% target bonus, and 600,000 stock options vesting over 4 years.
- No family relationships or material transactions with Sendek were reported.
- Juan Graham will receive severance per his existing employment agreement upon signing a separation agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/728387/000072838725000013/0000728387-25-000013-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/728387/000072838725000013/catx-20250902.htm
  HTML page:      https://secwatch.observer/filing/0000728387-25-000013

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer